Menten AI

Menten AI designs peptide and protein therapeutics using quantum…

San Francisco, United States · $3.8M raised

Employees
1–10
Website
menten.ai
Total Funding
$3.8M
Last Round
$3.6M SeedJun 2020
Rounds
3

About

Menten AI designs protein drugs and enzymes using quantum computing and machine learning. Their technology leapfrogs current computational methods making it possible to design previously intractable proteins. The team created the first protein design algorithm for current and near-term quantum computers and created the world’s first protein designed on a quantum computer. They are now working on 3 new proteins, including a peptide to prevent the spread of viruses like Covid-19. They have 2 paid pilot projects with multinational chemical companies and 4 LOI’s with pharma and biotech companies.

Summary

Menten AI is a Drug Discovery company based in San Francisco, United States. It has raised $3.8M in total across 3 rounds, most recently a $3.6M Seed round in Jun 2020. Investors include Uncork Capital, Khosla Ventures and Y Combinator.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJun 2020
$3.6M

Sign up to see all 3 rounds

Seed — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Menten AI on Indexed.vc
<a href="https://indexed.vc/companies/menten-ai"><img src="https://indexed.vc/api/badge/company/menten-ai" alt="Menten AI on Indexed.vc" width="260" height="76" /></a>